Our aim was to compare the inter-rater agreement about transvaginal ultrasonography (TVS) with magnetic resonance imaging (MRI) with regard to diagnosing adenomyosis and for assessing various predefined imaging features of adenomyosis, in the same set of women. The study cohort included 51 women, prospectively, consecutively recruited based on a clinical suspicion of adenomyosis. MRIs and TVS videoclips and 3D volumes were retrospectively assessed by four experienced radiologists and five experienced sonographers, respectively. Each rater subjectively evaluated the presence or absence of adenomyosis, as well as imaging features suggestive of adenomyosis. Fleiss kappa (κ) was used to reflect inter-rater agreement for categorical data, and the intraclass correlation coefficient (ICC) was used to reflect the reliability of quantitative data. Agreement between raters for diagnosing adenomyosis was higher for TVS than for MRI (κ = 0.42 vs. 0.28). MRI had a higher inter-rater agreement in assessing wall asymmetry, irregular junctional zone (JZ), and the presence of myometrial cysts, while TVU had a better agreement for assessing globular shape. MRI showed a moderate to good reliability for measuring the JZ (ICC = 0.57–0.82). For TVS, the JZ was unmeasurable in >50% of cases, and the remaining cases had low reliability (ICC = −0.31–0.08). We found that inter-rater agreement for diagnosing adenomyosis was higher for TVS than for MRI, despite the fact that MRI showed a higher inter-rater agreement in most specific features. Measurements of JZ in the coronal plane with 3D TVS were unreliable and thus unlikely to be useful for diagnosing adenomyosis.
Our aim was to compare the inter-rater agreement of Transvaginal ultrasonography (TVS) with Magnetic Resonance Imaging (MRI) regarding diagnosing adenomyosis and for various predefined imaging features of adenomyosis in the same set of women. MRIs were assessed by four experienced radiologists and 2D TVS videoclips and 3D ultrasound volumes were assessed by five experienced sonographers. Each rater subjectively evaluated the presence or absence of adenomyosis, assessed various imaging. Fleiss kappa (κ) was used to reflect inter-rater agreement for categorical data and the Intraclass correlation coefficient (ICC) to reflect the reliability of quantitative data. Agreement between raters for diagnosing adenomyosis was higher for TVS than for MRI (κ =0.42 vs.0.28). MRI had a higher inter-rater agreement in assessing wall asymmetry irregular Junctional Zone (JZ) presence of myometrial cysts, while TVU had a better agreement for globular shape. MRI showed a moderate-good reliability for measuring the JZ (ICC=0.57-0.82). For TVS, JZ was unmeasurable in > 50% of cases and the remaining cases had a low reliability (ICC=-0.31-0.08). We found that Inter-rater agreement for diagnosing adenomyosis was higher for TVS than for MRI, despite that MRI showed a higher inter-rater agreement in most specific features. Measurements of JZ in the coronal plane with 3D TVS were unreliable and thus unlikely to be useful for diagnosing adenomyosis.
To explore the optimal use of MRI including time point to predict early treatment response during definitive chemoradiotherapy in cervical carcinoma. Pilot study including 15 patients with cervical carcinoma stage IIB-IIIB (FIGO 2009) scheduled for chemoradiotherapy. All patients underwent four MRI examinations (at baseline, 3 weeks, 5 weeks, and 12 weeks after treatment start). Maximum tumor size, size change (Δsize), visibility on diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) mean and change in ADC (ΔADC) at the different time points were recorded. 7/15 patients relapsed during the study period, referred to as "poor prognosis" (PP) and the remaining 8/15 are referred to as "good prognosis" (GP). At all four time points, the tumors in the PP patients were larger than in the GP patients. Tumor size did change between the time point but this was not significant between the groups. Visible tumor on high b-value DWI reached a sensitivity and specificity for predicting prognostic group being highest at 5 weeks, 83 % (5/6) and 63 % (5/8), respectively. The combination of tumor size at baseline and visible tumor on DWI at 5 weeks, resulted in an area under the curve (AUC) = 0.83. At 12 weeks, no GP patients, but 2/7 PP patients showed visible tumor on DWI. Addition of ADC-values in the analysis did not improve the predictive value at any time point. This pilot study indicates that the tumor size on baseline MRI, combined with tumor visibility on DWI at 5 weeks, may predict outcome of chemoradiotherapy.